158 related articles for article (PubMed ID: 31030248)
1. Uterine carcinosarcoma: a primer for radiologists.
Ravishankar P; Smith DA; Avril S; Kikano E; Ramaiya NH
Abdom Radiol (NY); 2019 Aug; 44(8):2874-2885. PubMed ID: 31030248
[TBL] [Abstract][Full Text] [Related]
2. Uterine Carcinosarcomas.
Sagebiel TL; Bhosale PR; Patnana M; Faria SC; Devine CE
Semin Ultrasound CT MR; 2019 Aug; 40(4):295-301. PubMed ID: 31375170
[TBL] [Abstract][Full Text] [Related]
3. Uterine carcinosarcoma: A review of the literature.
Cantrell LA; Blank SV; Duska LR
Gynecol Oncol; 2015 Jun; 137(3):581-8. PubMed ID: 25805398
[TBL] [Abstract][Full Text] [Related]
4. Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma.
Chen X; Guo Q; Chen X; Zheng W; Kang Y; Cao D
BMC Med Imaging; 2024 Feb; 24(1):48. PubMed ID: 38373912
[TBL] [Abstract][Full Text] [Related]
5. Uterine carcinosarcoma with extensive extrauterine component.
Almeida PC; Amaral Ferreira L; Donato P
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34880043
[No Abstract] [Full Text] [Related]
6. Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma.
Inoue A; Yamaguchi K; Kurata Y; Murakami R; Abiko K; Hamanishi J; Kondoh E; Baba T; Kido A; Konishi I; Matsumura N
J Gynecol Oncol; 2017 Sep; 28(5):e62. PubMed ID: 28657223
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonographic Findings of Uterine Carcinosarcoma.
Zhao F; Xu Y; Zhang H; Ren Y
Gynecol Obstet Invest; 2019; 84(3):277-282. PubMed ID: 30504724
[TBL] [Abstract][Full Text] [Related]
8. Identification of distinct molecular subtypes of uterine carcinosarcoma.
An Y; Wang H; Jie J; Tang Y; Zhang W; Ji S; Guo X
Oncotarget; 2017 Feb; 8(9):15878-15886. PubMed ID: 28178664
[TBL] [Abstract][Full Text] [Related]
9. Current Status of Magnetic Resonance Imaging in Patients with Malignant Uterine Neoplasms: A Review.
Huang YT; Huang YL; Ng KK; Lin G
Korean J Radiol; 2019 Jan; 20(1):18-33. PubMed ID: 30627019
[TBL] [Abstract][Full Text] [Related]
10. Trends of uterine carcinosarcoma in the United States.
Matsuo K; Ross MS; Machida H; Blake EA; Roman LD
J Gynecol Oncol; 2018 Mar; 29(2):e22. PubMed ID: 29400015
[TBL] [Abstract][Full Text] [Related]
11. Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma.
Elshaikh MA; Modh A; Jhingran A; Biagioli MC; Coleman RL; Gaffney DK; Harkenrider MM; Heskett K; Jolly S; Kidd E; Lee LJ; Li L; Portelance L; Sherertz T; Venkatessan AM; Wahl AO; Yashar CM; Small W
Gynecol Oncol; 2020 Aug; 158(2):460-466. PubMed ID: 32475772
[TBL] [Abstract][Full Text] [Related]
12. Uterine carcinosarcomas: From pathology to practice.
Toboni MD; Crane EK; Brown J; Shushkevich A; Chiang S; Slomovitz BM; Levine DA; Dowdy SC; Klopp A; Powell MA; Thaker PH
Gynecol Oncol; 2021 Jul; 162(1):235-241. PubMed ID: 34030871
[TBL] [Abstract][Full Text] [Related]
13. Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis.
Hembree TN; Teer JK; Hakam A; Chiappori AA
Cancer Control; 2016 Jan; 23(1):61-6. PubMed ID: 27009459
[TBL] [Abstract][Full Text] [Related]
14. OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma.
An Y; Wang Q; Sun F; Zhang G; Wang F; Zhang L; Li Y; Ren W; Zhu W; Li Y; Ji S; Guo X
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899312
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Saito A; Nishikawa T; Yoshida H; Mizoguchi C; Kitadai R; Yamamoto K; Yazaki S; Kojima Y; Ishikawa M; Kato T; Yonemori K
Gynecol Oncol; 2023 Sep; 176():115-121. PubMed ID: 37506533
[TBL] [Abstract][Full Text] [Related]
16. Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma.
Li J; Xing X; Li D; Zhang B; Mutch DG; Hagemann IS; Wang T
Neoplasia; 2017 Feb; 19(2):100-111. PubMed ID: 28088687
[TBL] [Abstract][Full Text] [Related]
17. Carcinosarcoma of the uterus: MRI findings including diffusion-weighted imaging and MR spectroscopy.
Takeuchi M; Matsuzaki K; Harada M
Acta Radiol; 2016 Oct; 57(10):1277-84. PubMed ID: 26787673
[TBL] [Abstract][Full Text] [Related]
18. Current concepts in the imaging of uterine sarcoma.
Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
[TBL] [Abstract][Full Text] [Related]
19. A predictive diagnostic model using multiparametric MRI for differentiating uterine carcinosarcoma from carcinoma of the uterine corpus.
Kamishima Y; Takeuchi M; Kawai T; Kawaguchi T; Yamaguchi K; Takahashi N; Ito M; Arakawa T; Yamamoto A; Suzuki K; Ogawa M; Takeuchi M; Shibamoto Y
Jpn J Radiol; 2017 Aug; 35(8):472-483. PubMed ID: 28584958
[TBL] [Abstract][Full Text] [Related]
20. Neovascularization of uterine carcinosarcoma: report of two cases analyzed by color Doppler ultrasonography and microvessel density.
Emoto M; Udo T; Kubota M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
J Ultrasound Med; 1999 Apr; 18(4):315-9. PubMed ID: 10206221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
